Poalim Equity
VC Fund
Tel Aviv, Israel
Poalim Equity is a VC fund in Tel Aviv focused on Software and Manufacturing. Poalim Capital Markets Ltd. is a boutique investment banking firm that offers financial advisory services. The firm provides mergers and acquisitions, corporate divestiture, corporate recapitalizations and restructurings, leveraged buyouts, valuations and fairness opinions, private placements, and initial public offerings advisory services.Additionally, it offers feasibility study, private placement memorandum and investor presentation preparation, client road-show organization, and term sheet negotiation and closing services. The firm caters to corporations, institutional investors, and high net-worth individuals. It has strategic alliances with William Blair & Company, YES BANK, and Poalim Asia Direct. The firm was founded in 1990 and is based in Tel Aviv, Israel. Poalim Capital Markets Ltd. operates as a subsidiary of Bank Hapoalim B.M.
- Total investments:
- 91
- Last investment:
- Lead investor:
- 8%
- Fund size:
- $125M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Poalim Equity invests in
Stages Poalim Equity invests in
Countries Poalim Equity invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 16 contacts → | |||
Round size
- Series B
- $9M–$77M
Investment Focus
Industry
- Software 16 (18%)
- Manufacturing 11 (12%)
- Information Technology 10 (11%)
- FinTech 9 (10%)
- Financial Services 9 (10%)
Stage
- Funding Round 22 (24%)
- Post-IPO Equity 16 (18%)
- Series B 10 (11%)
- Series C 7 (8%)
- Series A 6 (7%)
Country
- United States 38 (42%)
- Israel 26 (29%)
- United Kingdom 2 (2%)
- Germany 1 (1%)
- Portugal 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adiel Gopas
Investment Banking & Tech investments
|
Investment Banking & Tech investments | Total investments: 0 | Find email | |
|
Ben Kornowski
Direct Investments Analyst
|
Direct Investments Analyst | Total investments: 0 | Find email | |
Dan Cohen
CFO
|
CFO | Total investments: 0 | Find email | |
Dorit Zak
Managing Director, Head of Alternatives and Strategic Partnerships
|
Managing Director, Head of Alternatives and Strategic Partnerships | Total investments: 0 | Find email | |
|
Eran Gersht
Head of Direct Investments
|
Head of Direct Investments | Total investments: 0 | Find email | |
| See all 16 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Buildots
|
Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project. | $130M / Series E / Sep 14, 2026 | |
FormX
|
formX develops technology-driven modular construction systems for residential projects such as accessory dwelling units, backyard studios, and single-family homes. The company combines software-guided design with prefabricated, interlocking components to streamline drafting, permitting, and on-site assembly. Its systems are engineered for use bylocal building crews with hand tools, reducing construction complexity and time compared to traditional methods. formX offers configurable solutions that support various layouts, finishes, and uses, including guest houses, rental units, home offices, and full-scale residences. Its approach focuses on integrating design, permitting, and construction into an end-to-end process for homeowners and real estate developers. | $12.5M / Seed / Jul 28, 2026 | |
Quantum Art
|
Quantum Art is a developer of full-stack quantum computing system technology. Its technology aims to develop first ion trap quantum computer based on cutting-edge research from the Weizmann Institute of Science and to realize the potential of quantum computing. The company was founded in 2022 and is headquartered in Ness Tziona, Israel. | $40M / Series A / Apr 27, 2026 | |
|
Buildots
|
Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project. | $45M / Series D / May 29, 2025 | |
Hailo
|
Hailo is an Israel-based deep learning company that develops a breakthrough specialized deep learning microprocessor to deliver data center performance to edge devices. The company aims to drive artificial intelligence to the edge. Its processors enable edge devices to go beyond handling sensors and streaming volumes of data for remoteprocessing–they can do the processing themselves.Hailo’s complete re-think of computer architecture breaks the barriers of traditional paradigms, accelerating the extremely heavy computation of deep neural networks. | $120M / Series C / Apr 02, 2024 | |
Assured Allies
|
Prevent what you can. Prepare for what you can’t.That's the simple yet powerful philosophy that drives us. There are proven tools and techniques that are available - right now - to help millions age successfully and prevent what we used to think of as inevitable. But many people don't know about them, or how to apply them. That'sthe gap we're filling - so more of us can make active - even aggressive- efforts to keep aging from disrupting our lives. But we all don't age in the same way. So we use data to identify different "course calculations'' - predicting a particular individual's aging curve. We then apply insights derived from large datasets to make effective personalized recommendations for successful aging. That's the "Prevent what you can '' half of our mission. The second half - preparation for the unexpected - is why we offer our platform through America's Most innovative and trusted insurance companies. The combination of prevention and preparation benefits individuals, their families, and society.Because our mission touches science and behavior change, we are a cross-disciplinary team of experienced entrepreneurs, clinicians, with offices in Tel Aviv and Boston, and backed by leading venture capital firms and strategic investors. | $42.5M / Series B / Mar 07, 2023 | |
MeMed
|
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse.Antibiotics are the most prescribed class of drugs worldwide with aglobal market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system.ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases. | $93M / Jan 10, 2022 | |
|
MeMed
|
MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse.Antibiotics are the most prescribed class of drugs worldwide with aglobal market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system.ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases. | $93M / Series E / Jan 10, 2022 | |
DustPhotonics
|
DustPhotonics develops and manufactures pluggable optical modules and solutions for data center, enterprise and HPC applications. Its innovative products and technology, such as AuraDP™, are targeted at enabling the next generation of optical modules and connectivity. DustPhotonics was founded in 2017 with offices in Modi'in, Israel andCupertino, California. | $33M / Series B / Oct 28, 2021 | |
Serverfarm
|
Serverfarm is a data center company providing a complete data center oversight from facility to IT infrastructure management. | $75M / Debt Financing / Oct 24, 2021 | |
| See all 91 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Poalim Equity invest in?
Poalim Equity invests primarily in Software, Manufacturing and Information Technology startups, most often at Funding Round and Post-IPO Equity stage. Most of the 91 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Poalim Equity's check size?
Poalim Equity typically joins rounds of $9M–$77M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Poalim Equity participates in.
How do I contact Poalim Equity?
Public channels for Poalim Equity include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Poalim Equity?
The team at Poalim Equity includes Adiel Gopas (Investment Banking & Tech investments), Ben Kornowski (Direct Investments Analyst) and Dan Cohen (CFO), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
